EUVIMEDΑνακαλύψτε το EUVIMED
Crossref

The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia

Wen-Ting Chen, Shu-Wen Wang, Ying Huang, Rui-Mei Tang, Dan Liu, Gu-Yun Wang

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05964-w ↗

At a glance

Journal article in Annals of Hematology, 2024. Written by Wen-Ting Chen and 5 co-authors. Institution: Department of Hematology, Hainan General Hospital, Haikou, Hainan, 570311, China. 18889277281@163.com. Major MEDLINE topics: Anemia, Aplastic, Quality of Life. Cited 3 times so far (Crossref); 24 references.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

This study aimed to investigate the effect of hetrombopag combined with conventional treatment on immune function in patients with severe aplastic anemia (SAA). Patients were categorized into the control group (n = 50, receiving conventional treatment only) and experimental group (n = 50, receiving hetrombopag combined with conventional treatment). Before treatment and at weeks 18, 24, and 52 after treatment, the two groups were compared in routine blood test indicators, natural killer (NK) cell activity, and peripheral blood inflammatory factor levels. The overall remission rate and incidence of adverse events were also compared between the two groups. Outpatient or telephone follow-up was performed before treatment and at weeks 18, 24, and 52 after treatment to observe patients' immune function, treatment outcome, quality of life, and adverse events. Hemoglobin (Hb), and platelet count (PLT) (P < 0.05), and a rise in NK cell activity (P < 0.05). Interleukin (IL-10) levels were significantly higher, while IL-6 levels were significantly lower in the experimental group compared to the control group (P < 0.05). After receiving the treatment, all scores of SF-36 domains in both groups were higher than before treatment, particularly with higher scores in the experimental group (P < 0.05). Hetrombopag combined with conventional treatment improved the immune function and hematopoiesis of patients with SAA.

Subjects

MeSH terms (MEDLINE)

Anemia, AplasticQuality of LifeHumansMaleFemaleAdultMiddle AgedAdolescentKiller Cells, NaturalYoung AdultDrug Therapy, CombinationSeverity of Illness Index

Author keywords

36-Item Short Form SurveyHetrombopagImmune functionQuality of lifeSevere aplastic anemia

Authors and institutions

  • Department of Hematology, Hainan General Hospital, Haikou, Hainan, 570311, China. 18889277281@163.com.
  • Department of Clinical Laboratory, Hainan General Hospital, Haikou, Hainan, 570311, China.
  • Department of Hematology, Hainan General Hospital, Haikou, Hainan, 570311, China.

Cite

APA

Chen, W. T., Wang, S. W., Huang, Y., Tang, R. M., Liu, D., & Wang, G. Y. (2024). The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia. Annals of Hematology. https://doi.org/10.1007/s00277-024-05964-w

Vancouver

Chen WT, Wang SW, Huang Y, Tang RM, Liu D, Wang GY. The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia. Annals of Hematology. 2024. doi:10.1007/s00277-024-05964-w

BibTeX
@article{Chen2024,
  author = {Chen, Wen-Ting and Wang, Shu-Wen and Huang, Ying and Tang, Rui-Mei and Liu, Dan and Wang, Gu-Yun},
  title = {The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05964-w}
}
Start for free →